chimeric therapeutics (asx:chm): positive initial phase 1 clinical data
Published 2 years ago • 120 plays • Length 6:51Download video MP4
Download video MP3
Similar videos
-
27:01
chimeric therapeutics: cltx car t presents positive initial phase 1 clinical data
-
15:20
chimeric therapeutics (asx:chm) - webinar presentation
-
15:24
chimeric therapeutics (asx:chm) - webinar presentation
-
16:02
chimeric therapeutics (asx:chm) - webinar presentation
-
5:04
chimeric therapeutics (asx:chm) - positive safety data for glioblastoma trial
-
30:20
chimeric therapeutics (asx: chm) ceo jennifer chow presentation from the nwr virtual healthcare day.
-
21:00
chimeric therapeutics | final results in phase 1 trial of core nk platform
-
1:06:53
new treatment horizon : chimeric antigen receptor car t cell therapy
-
37:11
transcriptomics of cirs
-
5:08
axumin vs pylarify psma pet/ct
-
24:58
chimeric therapeutics (asx: chm) presentation, nwr virtual healthcare conference
-
31:06
chimeric therapeutics (asx: chm) presentation | nwr virtual healthcare conference
-
13:24
chimeric therapeutics (asx:chm): good prospects for licensing deals
-
13:44
chimeric therapeutics (asx:chm) presentation, fnn investor event, february 2022
-
2:16
chimeric therapeutics (asx:chm) first patient dosed in phase 1/2 trial of chm cdh17
-
0:21
chm positive preliminary phase 1a data
-
10:34
chimeric therapeutics (asx: chm) ceo jennifer chow's presentation at the ausbiotech conference 2021
-
5:48
chimeric therapeutics (asx:chm) - bringing cell therapy to more patients with cancer, august 2021
-
6:03
chimeric ceo jennifer chow speaks to proactive investors post positive initial phase 1 clinical data
-
5:03
chimeric therapeutics (asx:chm) - clinical stage t cell therapy biotech targeting glioblastoma
-
12:47
chimeric therapeutics (asx:chm) presentation, fnn online investor event, june 2021
-
8:13
chimeric’s new cdh17 car t (asx:chm)